Role-based routing
Friendly advisory cards for hospital biomeds, sleep directors, ASC teams, long-term care, home health, and GPO sourcing.
Multi-platform home-care discharge kits, FDA 510(k) recall workflow, UDI-DI look-up, IEC 60601 electrical file routing, and spare-parts staging for CPAP / BiPAP fleets. Typical planning window: filter and cushion replenishment every 30–90 days depending on IFU and local infection-prevention rules.
Full-face, nasal, and pillow mask rotation against leak tolerance and therapy pressure range; leak coaching protocols; clinic-to-home handoff checklists; and documentation of intended-use statements before auto-titrating APAP or BiPAP step-up is considered.
Procedure-day recovery supplies, sterile barrier consumables with sterility assurance level (SAL) notes where packaging claims apply, and AAMI ST91 / ISO 17664 reprocessing documentation paths when reusable instruments are in scope.
Shared-device infection-control bundles, caregiver training packs, biocompatibility-tested cushion materials where listed, and replenishment cadence for tubing, filters, and water chambers under the current IFU—not a generic cleaning claim.
Portable CPAP kits, mask fit coaching, caregiver teach-back, SpO2 accessory review only when a cleared pulse-oximetry path applies, and 30-day check-in planning with usage-hour exports where HL7 FHIR or portal paths are available.
Premier / Vizient / HealthTrust contract pricing questions, total cost of ownership inputs (device + cushions + filters + service), UDI / GUDID packet readiness, and reference-level ISO 13485 scope letters—never a blanket clearance assumption across SKUs.
Quick selector
Use the checklist as a routing brief. Final modality choice (CPAP / APAP vs BiPAP / ASV), mask family, and infection-control route still depend on clinical indication, payer rules, and the exact product reference.
For obstructive sleep apnea and complex respiratory insufficiency, device selection between fixed-pressure CPAP, auto-adjusting APAP, BiPAP, and adaptive servo-ventilation (ASV) remains contested among sleep medicine and pulmonology specialists. Resmed presents both sides so care teams can match modality to indication—not catalog preference.
| Decision factor | CPAP / APAP | BiPAP / ASV |
|---|---|---|
| Typical first-line use | Moderate–severe OSA with acceptable fixed or auto pressure tolerance | High-pressure intolerance, COPD overlap, complex / central apnea pathways where indicated |
| Device and titration complexity | Lower device cost, simpler titration, broadest insurance coverage patterns | Higher modality complexity; requires clear clinical indication and monitoring plan |
| Adherence drivers | Strong long-term adherence data when interface fit and humidification are managed | May improve comfort at high pressures; does not replace mask fit or leak coaching |
| Risk / boundary | May be insufficient for complex sleep apnea or NIV transition needs | ASV and certain BiPAP paths are contraindicated or restricted in specific cardiac populations—verify current labeling |
| When it fits | Home-health and sleep-clinic OSA programs with standard PAP pathways | Pulmonary / sleep programs with documented need beyond CPAP / APAP |
Route the right specialist
No protected health information. Include role, care setting, candidate product families, and destination market.